GH Research Logo_white background.jpg
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
02. März 2023 07:00 ET | GH Research PLC
DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Logo_white background.jpg
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
09. Januar 2023 07:30 ET | GH Research PLC
Initial approvals received for Phase 2b trial of GH001 in TRD (GH001-TRD-201), initiation of this trial expected in Q1 2023Development of proprietary aerosol delivery device for GH001 progressed, IND...
GH Research Logo_white background.jpg
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
10. November 2022 07:05 ET | GH Research PLC
DUBLIN, Ireland, Nov. 10, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Logo_white background.jpg
GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates
23. August 2022 07:00 ET | GH Research PLC
DUBLIN, Ireland, Aug. 23, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Logo_white background.jpg
GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates
18. Mai 2022 07:00 ET | GH Research PLC
DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Logo_white background.jpg
GH Research Reports Full Year 2021 Financial Results and Provides Business Updates
28. März 2022 07:04 ET | GH Research PLC
DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...
GH Research Logo_white background.jpg
GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates
06. Dezember 2021 07:10 ET | GH Research PLC
DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Logo_white background.jpg
GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression
06. Dezember 2021 07:00 ET | GH Research PLC
Primary endpoint met in Phase 2 part of clinical trial for GH001 in TRD 7 of 8 patients (87.5%) were in remission (MADRS ≤10) at day 7 after dosing (p<0.0001) Secondary endpoints met Mean change...
GH Research Logo_white background.jpg
GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results
23. September 2021 17:25 ET | GH Research PLC
DUBLIN, Ireland, Sept. 23, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...